Diabetes is not prevented by Foxp3-transduced CD4+T cells under the IL-12Rβ2 promoter control

Molecular Immunology

Volumn 45, Issue 14, 2008, Pages 3814-3817

  Wang, Renxi ^a   Han, Gencheng ^a   Wang, Jianan ^a   Song, Lun ^a   Chen, Guojiang ^a   Xu, Ruonan ^a   Wang, Liyan ^a   Li, Xia ^b   Shen, Beifen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HENAN UNIVERSITY   (China)

Author keywords

CD4+Foxp3+Treg cell; Foxp3; IFN ; IL 12R 2; Th1 cell

Indexed keywords

INTERLEUKIN 12 RECEPTOR BETA2; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIABETES MELLITUS; FORKHEAD TRANSCRIPTION FACTORS; LENTIVIRUS; MICE; MICE, INBRED NOD; PROMOTER REGIONS, GENETIC; TH1 CELLS; TRANSDUCTION, GENETIC;

MUS;

EID: 48049111172     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.05.016     Document Type: Article

References (13)

1. Bach J.F., and Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19 (2001) 131-161
2. Egen J.G., Kuhns M.S., and Allison J.P. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3 (2002) 611-618
3. Glimcher L.H., and Murphy K.M. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 14 (2000) 1693-1711
4. Han G., Li Y., Wang J., Wang R., Chen G., Song L., Xu R., Yu M., Wu X., Qian J., and Shen B. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD (500-585). J. Immunol. 174 (2005) 4516-4524
5. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
6. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., and Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366 (1993) 69-72
7. Murphy K.M., Ouyang W., Farrar J.D., Yang J., Ranganath S., Asnagli H., Afkarian M., and Murphy T.L. Signaling and transcription in T helper development. Annu. Rev. Immunol. 18 (2000) 451-494
8. Presky D.H., Yang H., Minetti L.J., Chua A.O., Nabavi N., Wu C.Y., Gately M.K., and Gubler U. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14002-14007
9. Robinson D.S., and O'Garra A. Further checkpoints in Th1 development. Immunity 16 (2002) 755-758
10. Song L., Wang J., Wang R., Yu M., Sun Y., Han G., Li Y., Qian J., Scott D.W., Kang Y., Soukhareva N., and Shen B. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?. Gene Ther. 11 (2004) 1487-1496
11. Szabo S.J., Dighe A.S., Gubler U., and Murphy K.M. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper I (Th1) and Th2 cells. J. Exp. Med. 185 (1997) 817-824
12. Wang R., Han G., Wang J., Song L., Chen G., Xu R., Yu M., Qian J., Shen B., and Li Y. Foxp3-expressing CD4+T cells under the control of IFN-promoter prevent diabetes in NOD mice. Mol. Ther. 15 (2007) 1551-1557
13. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226